Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease thromboembolism
Phenotype C0040053|thrombosis
Sentences 24
PubMedID- 22268621 Lower extremity deep venous thrombosis with fatal pulmonary thromboembolism caused by benign pelvic space-occupying lesions--an overview.
PubMedID- 22735868 Isolated deep vein thrombosis represented 21% of all venous thromboembolic events, and when considering the whole population, ctv was associated with an increment in diagnostic yield of 3.1%.
PubMedID- 25928269 Table 1 summarizes the ten studies and shows how many criteria were selected as feasibility ec.table 1list of selected studiestitleefpia partnerdisease categoryoriginal number of ecnumber of feasibility criteriaonce – daily oral direct factor xa inhibitor rivaroxaban in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis or pulmonary embolism.
PubMedID- 26068539 In the hokusai-vte study, edoxaban was as effective as warfarin for the prevention of recurrent venous thromboembolism (vte) in patients with deep venous thrombosis, pulmonary embolism, or both, but with a lesser risk of bleeding.
PubMedID- 23657428 Since the introduction in the 1950s, warfarin has become the commonly used oral anticoagulant for the prevention of thromboembolism in patients with deep vein thrombosis, atrial fibrillation or prosthetic heart valve replacement.
PubMedID- 25033001 It is indicated for the prevention of recurrent thrombosis in patients with venous thromboembolism (vte), which includes deep venous thrombosis and pulmonary embolism, and ischemic stroke.
PubMedID- 23663039 Method: we present 3 cases of mechanical mitral valve thrombosis complicated by thromboembolism, who were all examined and followed-up by 2d transthoracic echocardiography (tte), 2dtee, and rt-3dtee.
PubMedID- 26091847 Warfarin is a commonly prescribed oral anticoagulant, used to prevent thromboembolic diseases in patients with deep vein thrombosis, atrial fibrillation, recurrent stroke, or heart valve prosthesis [30].
PubMedID- 23968500 Chronic oral anticoagulation with warfarin is the major treatment strategy to attenuate thromboembolism or stroke in patients with deep vein thrombosis, pulmonary embolism, heart failure and atrial fibrillation.
PubMedID- 26113804 Previous studies had identified other risk factors associated with thrombosis including history of venous thromboembolic events, type of chemotherapy received and concomitant medication (including anti-platelet therapy and low-molecular weight heparin) [3,19].
PubMedID- 21162604 Venous thromboembolism begins with deep vein thrombosis (dvt), which forms in the deep veins of the leg (calf) or pelvis.
PubMedID- 25469146 A 71-year-old woman who had suffered from pulmonary thromboembolism with deep vein thrombosis for 12 years presented the hospital with a huge thoracic aortic aneurysm.
PubMedID- 22412776 However, it should be used with caution in patients with risk for thrombosis (eg, history of a thromboembolic event or a family history of thromboembolic disease).
PubMedID- 26532122 A mixed treatment comparison (mtc) to compare the efficacy of anti-thrombotic agents in treatment and secondary prevention of venous thromboembolism (vte) in patients with deep vein thrombosis (dvt).
PubMedID- 23800549 The mean thickness of the ring thrombosis in patients with thromboembolism was greater than that in patients without thromboembolism (3.8 +/- 0.9 vs 2.8 +/- 0.7 mm, p <0.001).
PubMedID- 25312667 And the pulmonary thromboembolism (pte) patients with deep venous thrombosis (dvt) were enrolled into pte group.
PubMedID- 24167803 Although subclavian artery thrombosis complicated by cerebral thromboembolism is uncommon, a number of case studies have reported on cerebral embolism from a subclavian artery thrombotic pathology.1) the pathogenesis of infarcts in the vertebrobasilar and carotid distribution is generally believed to be due to propagation or retrograde embolism from a subclavian artery thrombus.
PubMedID- 25587472 Deep vein thrombosis (dvt) may lead to pulmonary thromboembolism (pe), and the latter is culpable for many deaths annually in the united states; however, dvt as a complication of uterine leiomyoma has rarely been reported.
PubMedID- 22075319 The indication for filter insertion was acute bleeding (46.1%) or surgery (24.2%) in patients with acute thrombosis, prevention of venous thromboembolism in trauma (13.3%), potential bleeding in patients with deep vein thrombosis (9.1%) thromboembolism while on adequate anticoagulation (5.7%) and other (1.3%).
PubMedID- 25810936 That cancer patients with venous thrombosis have higher risk of recurrent thromboembolism and major bleeding during anticoagulant therapy than those without malignancy [16].
PubMedID- 21543674 Results: seventeen patients (4.0%) (95% confidence interval: 2.5% to 6.3%) had a venous thromboembolic event, ten with deep venous thrombosis and seven with nonfatal pulmonary embolism.
PubMedID- 25749028 The key driver for defining categories was the potential for identifying a specific intervention (eg, preventing hospital-acquired deep venous thrombosis by improving administration of venous thromboembolism (vte) prophylaxis31).
PubMedID- 22263185 Seventy percent of the detected pulmonary thromboembolisms are combined with deep vein thrombosis in the lower extremities.
PubMedID- 21912556 Mobile right-sided thrombi, in particular, are thought to be a severe form of venous thromboembolism, arising from deep vein thrombosis [1].

Page: 1